KD Logo

A Guide To The Risks Of Investing In Jazz Pharmaceuticals plc (JAZZ)

In a filing, Jazz Pharmaceuticals plc revealed its SVP, Technical Operations Henderson Mary Elizabeth unloaded Company’s shares for reported $0.15 million on Sep 06 ’24. In the deal valued at $108.30 per share,1,410 shares were sold. As a result of this transaction, Henderson Mary Elizabeth now holds 14,531 shares worth roughly $-1.61 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Henderson Mary Elizabeth bought 2,691 shares, generating $296,010 in total proceeds.

Before that, Winningham Rick E bought 3,075 shares. Jazz Pharmaceuticals plc shares valued at $341,325 were divested by the Director at a price of $111.00 per share.

Goldman initiated its Jazz Pharmaceuticals plc [JAZZ] rating to a Buy in a research note published on June 05, 2024; the price target was $169. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who began to cover the stock in early January with a ‘”an Outperform”‘ rating. UBS also remained covering JAZZ and has decreased its forecast on November 27, 2023 with a “Neutral” recommendation from previously “Buy” rating. Raymond James started covering the stock on September 29, 2023. It rated JAZZ as “a Mkt perform”.

Price Performance Review of JAZZ

On Monday, Jazz Pharmaceuticals plc [NASDAQ:JAZZ] saw its stock jump 2.05% to $111.03. Over the last five days, the stock has gained 2.31%. Jazz Pharmaceuticals plc shares have fallen nearly -9.73% since the year began. Nevertheless, the stocks have fallen -13.27% over the past one year. While a 52-week high of $137.38 was reached on 02/26/24, a 52-week low of $99.06 was recorded on 07/10/24. SMA at 50 days reached $110.50, while 200 days put it at $113.73.

Levels Of Support And Resistance For JAZZ Stock

The 24-hour chart illustrates a support level at 109.59, which if violated will result in even more drops to 108.15. On the upside, there is a resistance level at 111.81. A further resistance level may holdings at 112.59. The Relative Strength Index (RSI) on the 14-day chart is 55.25, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.07, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 27.19%. Stochastics %K at 45.67% indicates the stock is a holding.

How much short interest is there in Jazz Pharmaceuticals plc?

A steep rise in short interest was recorded in Jazz Pharmaceuticals plc stocks on 2024-09-30, growing by 1.49 million shares to a total of 3.38 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 1.89 million shares. There was a rise of 43.98%, which implies that there is a positive sentiment for the stock.

Most Popular